144 related articles for article (PubMed ID: 15803357)
41. Population-based case-control study of AhR (aryl hydrocarbon receptor) and CYP1A2 polymorphisms and breast cancer risk.
Long JR; Egan KM; Dunning L; Shu XO; Cai Q; Cai H; Dai Q; Holtzman J; Gao YT; Zheng W
Pharmacogenet Genomics; 2006 Apr; 16(4):237-43. PubMed ID: 16538170
[TBL] [Abstract][Full Text] [Related]
42. Interleukin-10 promoter polymorphisms in myasthenia gravis.
Alseth EH; Nakkestad HL; Aarseth J; Gilhus NE; Skeie GO
J Neuroimmunol; 2009 May; 210(1-2):63-6. PubMed ID: 19299022
[TBL] [Abstract][Full Text] [Related]
43. Genetic variation in pro-inflammatory cytokines (interleukin-1beta, interleukin-1alpha and interleukin-6) associated with the aggressive forms, survival, and relapse prediction of breast carcinoma.
Snoussi K; Strosberg AD; Bouaouina N; Ben Ahmed S; Chouchane L
Eur Cytokine Netw; 2005 Dec; 16(4):253-60. PubMed ID: 16464738
[TBL] [Abstract][Full Text] [Related]
44. Genetic, epidemiological and biological analysis of interleukin-10 promoter single-nucleotide polymorphisms suggests a definitive role for -819C/T in leprosy susceptibility.
Pereira AC; Brito-de-Souza VN; Cardoso CC; Dias-Baptista IM; Parelli FP; Venturini J; Villani-Moreno FR; Pacheco AG; Moraes MO
Genes Immun; 2009 Mar; 10(2):174-80. PubMed ID: 19110537
[TBL] [Abstract][Full Text] [Related]
45. Genetic variation in IL-8 associated with increased risk and poor prognosis of breast carcinoma.
Snoussi K; Mahfoudh W; Bouaouina N; Ahmed SB; Helal AN; Chouchane L
Hum Immunol; 2006; 67(1-2):13-21. PubMed ID: 16698420
[TBL] [Abstract][Full Text] [Related]
46. Genetic polymorphisms of TGF-beta1 & TNF-beta and breast cancer risk.
Lee KM; Park SK; Hamajima N; Tajima K; Yoo KY; Shin A; Noh DY; Ahn SH; Hirvonen A; Kang D
Breast Cancer Res Treat; 2005 Mar; 90(2):149-55. PubMed ID: 15803361
[TBL] [Abstract][Full Text] [Related]
47. Interleukin-10 -1082 promoter polymorphism is associated with schizophrenia in a Han Chinese sib-pair study.
He G; Zhang J; Li XW; Chen WY; Pan YX; Yang FP; Gu NF; Feng GY; Yang SL; He JY; Liu BX; Peng YW; Liu J; He L
Neurosci Lett; 2006 Feb; 394(1):1-4. PubMed ID: 16378687
[TBL] [Abstract][Full Text] [Related]
48. Interleukin-10 promoter single-nucleotide polymorphisms as markers for disease susceptibility and disease severity in leprosy.
Moraes MO; Pacheco AG; Schonkeren JJ; Vanderborght PR; Nery JA; Santos AR; Moraes ME; Moraes JR; Ottenhoff TH; Sampaio EP; Huizinga TW; Sarno EN
Genes Immun; 2004 Nov; 5(7):592-5. PubMed ID: 15306847
[TBL] [Abstract][Full Text] [Related]
49. Association of a progesterone receptor gene +331 G/A polymorphism with breast cancer risk: a meta-analysis.
Yang DS; Sung HJ; Woo OH; Park KH; Woo SU; Kim AR; Lee ES; Lee JB; Kim YH; Kim JS; Seo JH
Cancer Genet Cytogenet; 2010 Jan; 196(2):194-7. PubMed ID: 20082859
[TBL] [Abstract][Full Text] [Related]
50. Interleukin-10 -592C/A, but not -1082A/G promoter single nucleotide polymorphism, is associated with a decreased risk of colorectal cancer in an ethnic Kashmiri population: a case-control study.
Banday MZ; Sameer AS; Chowdri NA; Haq E
Eur J Cancer Prev; 2017 Nov; 26(6):476-490. PubMed ID: 28538040
[TBL] [Abstract][Full Text] [Related]
51. An interleukin-10 promoter polymorphism may influence tumor development in renal cell carcinoma.
Havranek E; Howell WM; Fussell HM; Whelan JA; Whelan MA; Pandha HS
J Urol; 2005 Mar; 173(3):709-12. PubMed ID: 15711248
[TBL] [Abstract][Full Text] [Related]
52. Interleukin-10 gene promoter polymorphism is not associated with schizophrenia in the Korean population.
Jun TY; Pae CU; Kim KS; Han H; Serretti A
Psychiatry Clin Neurosci; 2003 Apr; 57(2):153-9. PubMed ID: 12667161
[TBL] [Abstract][Full Text] [Related]
53. Susceptibility to primary Epstein-Barr virus infection is associated with interleukin-10 gene promoter polymorphism.
Helminen ME; Kilpinen S; Virta M; Hurme M
J Infect Dis; 2001 Sep; 184(6):777-80. PubMed ID: 11517440
[TBL] [Abstract][Full Text] [Related]
54. IL-8 -251A/T polymorphism is associated with decreased cancer risk among population-based studies: evidence from a meta-analysis.
Gao LB; Pan XM; Jia J; Liang WB; Rao L; Xue H; Zhu Y; Li SL; Lv ML; Deng W; Chen TY; Wei YG; Zhang L
Eur J Cancer; 2010 May; 46(8):1333-43. PubMed ID: 20400292
[TBL] [Abstract][Full Text] [Related]
55. Polymorphic haplotypes of the interleukin-10 5' flanking region determine variable interleukin-10 transcription and are associated with particular phenotypes of juvenile rheumatoid arthritis.
Crawley E; Kay R; Sillibourne J; Patel P; Hutchinson I; Woo P
Arthritis Rheum; 1999 Jun; 42(6):1101-8. PubMed ID: 10366102
[TBL] [Abstract][Full Text] [Related]
56. The interleukin-6 gene: a susceptibility factor that may contribute to racial and ethnic disparities in breast cancer mortality.
Berger FG
Breast Cancer Res Treat; 2004 Dec; 88(3):281-5. PubMed ID: 15609131
[TBL] [Abstract][Full Text] [Related]
57. Polymorphisms in promoter regions of IL-6 and IL-10 genes in breast cancer: a case-control study.
AlSuhaibani ES; Kizilbash NA; Malik S; Dasti JI; Al Beladi F; El-Morshedi N
Genet Mol Res; 2016 Mar; 15(1):. PubMed ID: 27050979
[TBL] [Abstract][Full Text] [Related]
58. Interleukin-10 (IL-10) promoter genotypes are associated with lung cancer risk in Taiwan males and smokers.
Hsia TC; Chang WS; Liang SJ; Chen WC; Tu CY; Chen HJ; Yang MD; Tsai CW; Hsu CM; Tsai CH; Bau DT
Anticancer Res; 2014 Dec; 34(12):7039-44. PubMed ID: 25503130
[TBL] [Abstract][Full Text] [Related]
59. Interleukin-10 polymorphisms in Spanish type 1 diabetes patients.
Urcelay E; Santiago JL; de la Calle H; MartÃnez A; Figueredo A; Fernández-Arquero M; de la Concha EG
Genes Immun; 2004 Jun; 5(4):306-9. PubMed ID: 15057267
[TBL] [Abstract][Full Text] [Related]
60. Genetic variants of the sulfotransferase 1A1 and breast cancer risk.
Langsenlehner U; Krippl P; Renner W; Yazdani-Biuki B; Eder T; Wolf G; Wascher TC; Paulweber B; Weitzer W; Samonigg H
Breast Cancer Res Treat; 2004 Sep; 87(1):19-22. PubMed ID: 15377847
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
